EcoDrugPlus

Prostaglandin E2 Receptor Ep1 Subtype-Like

Ensembl ID : ENSPKIG00000006939
Gene Symbol: LOC111856343
3 Cross references
164 Possible Orthologues:

Prostaglandin E2 Receptor Ep2 Subtype-Like

Ensembl ID : ENSPKIG00000022110
Gene Symbol: LOC111859947
3 Cross references
170 Possible Orthologues:

Prostaglandin F Receptor (Fp)

Ensembl ID : ENSPKIG00000008959
Gene Symbol: PTGFR
1 Cross references
195 Possible Orthologues:

Prostaglandin G/h Synthase 2-Like

Ensembl ID : ENSPKIG00000006786
Gene Symbol: LOC111840107
3 Cross references
188 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSPKIG00000010282
Gene Symbol: PTGIR
3 Cross references
187 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSPKIG00000014608
Gene Symbol: PTGS1
3 Cross references
210 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSPKIG00000005344
Gene Symbol: PTGS1
2 Cross references
210 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2a

Ensembl ID : ENSPKIG00000016720
Gene Symbol: PTGS2A
1 Cross references
211 Possible Orthologues:

Proteasomal Ubiquitin Receptor Adrm1-Like

Ensembl ID : ENSPKIG00000012305
Gene Symbol: LOC111855272
3 Cross references
193 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSPKIG00000023584
Gene Symbol: PSMA1
3 Cross references
269 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSPKIG00000018431
Gene Symbol: PSMA2
3 Cross references
215 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSPKIG00000015367
Gene Symbol: PSMA3
3 Cross references
239 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).